Molecular Biology of the Cell Call for Nominations: MBC Editor-in-Chief

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.01-11-0530 on June 6, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01-11-0530v1
13/8/2841    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rintoul, R. C.
Right arrow Articles by Sethi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rintoul, R. C.
Right arrow Articles by Sethi, T.

Vol. 13, Issue 8, 2841-2852, August 2002

Cross-Linking CD98 Promotes Integrin-like Signaling and Anchorage-independent Growth

Robert C. Rintoul,*dagger Robert C. Buttery,*dagger Alison C Mackinnon,* Weng Sie Wong,* Deane Mosher,Dagger Christopher Haslett,* and Tariq Sethi*§

 *Lung Inflammation Group, Centre for Inflammation Research, University of Edinburgh, Edinburgh EH8 9AG, United Kingdom; and  Dagger Departments of Medicine and Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin 53706

CD98, an early marker of T-cell activation, is an important regulator of integrin-mediated adhesion events. Previous studies suggest that CD98 is coupled to both cellular activation and transformation and is involved in the pathogenesis of viral infection, inflammatory disease, and cancer. Understanding of the molecular mechanisms underlying CD98 activity may have far-reaching practical applications in the development of novel therapeutic strategies in these disease states. Using small cell lung cancer cell lines, which are nonadherent, nonpolarized, and highly express CD98, we show that, in vitro, under physiological conditions, CD98 is constitutively associated with beta 1 integrins regardless of activation status. Cross-linking CD98 with the monoclonal antibody 4F2 stimulated phosphatidylinositol (PI) 3-kinase, PI(3,4,5)P3, and protein kinase B in the absence of integrin ligation or extracellular matrix engagement. Furthermore, cross-linking CD98 promoted anchorage-independent growth. Using fibroblasts derived from beta 1 integrin null stem cells (GD25), wild-type GD25beta 1, or GD25 cells expressing a mutation preventing beta 1 integrin-dependent FAK phosphorylation, we demonstrate that a functional beta 1 integrin is required for CD98 signaling. We propose that by cross-linking CD98, it acts as a "molecular facilitator" in the plasma membrane, clustering beta 1 integrins to form high-density complexes. This results in integrin activation, integrin-like signaling, and anchorage-independent growth. Activation of PI 3-kinase may, in part, explain cellular transformation seen on overexpressing CD98. These results may provide a paradigm for events involved in such diverse processes as inflammation and viral-induced cell fusion.


dagger R.C.R. and R.C.B. contributed equally to this work.

§ Corresponding author. E-mail address: t.sethi{at}ed.ac.uk.


Molecular Biology of the Cell
Vol. 13, 2841-2852, August 2002
Copyright © 2002 by The American Society for Cell Biology



This article has been cited by other articles:


Home page
J. Virol.Home page
M. V. Veettil, S. Sadagopan, N. Sharma-Walia, F.-Z. Wang, H. Raghu, L. Varga, and B. Chandran
Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ({alpha}V{beta}5, {alpha}V{beta}3, and {alpha}3{beta}1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection
J. Virol., December 15, 2008; 82(24): 12126 - 12144.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. MacKinnon, S. L. Farnworth, P. S. Hodkinson, N. C. Henderson, K. M. Atkinson, H. Leffler, U. J. Nilsson, C. Haslett, S. J. Forbes, and T. Sethi
Regulation of Alternative Macrophage Activation by Galectin-3
J. Immunol., February 15, 2008; 180(4): 2650 - 2658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. W. Prager, C. C. Feral, C. Kim, J. Han, and M. H. Ginsberg
CD98hc (SLC3A2) Interaction with the Integrin beta Subunit Cytoplasmic Domain Mediates Adhesive Signaling
J. Biol. Chem., August 17, 2007; 282(33): 24477 - 24484.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Schubert-Unkmeir, O. Sokolova, U. Panzner, M. Eigenthaler, and M. Frosch
Gene Expression Pattern in Human Brain Endothelial Cells in Response to Neisseria meningitidis
Infect. Immun., February 1, 2007; 75(2): 899 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Abdala-Valencia and J. M. Cook-Mills
VCAM-1 Signals Activate Endothelial Cell Protein Kinase C{alpha} via Oxidation
J. Immunol., November 1, 2006; 177(9): 6379 - 6387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Fernandez, M. Jimenez-Vidal, M. Calvo, A. Zorzano, F. Tebar, M. Palacin, and J. Chillaron
The Structural and Functional Units of Heteromeric Amino Acid Transporters: THE HEAVY SUBUNIT rBAT DICTATES OLIGOMERIZATION OF THE HETEROMERIC AMINO ACID TRANSPORTERS
J. Biol. Chem., September 8, 2006; 281(36): 26552 - 26561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Thelemann, F. Petti, G. Griffin, K. Iwata, T. Hunt, T. Settinari, D. Fenyo, N. Gibson, and J. D. Haley
Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells
Mol. Cell. Proteomics, April 1, 2005; 4(4): 356 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Cai, N. Bulus, P. M. Fonseca-Siesser, D. Chen, S. K. Hanks, A. Pozzi, and R. Zent
CD98 modulates integrin {beta}1 function in polarized epithelial cells
J. Cell Sci., March 1, 2005; 118(5): 889 - 899.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. C. Feral, N. Nishiya, C. A. Fenczik, H. Stuhlmann, M. Slepak, and M. H. Ginsberg
CD98hc (SLC3A2) mediates integrin signaling
PNAS, January 11, 2005; 102(2): 355 - 360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. C. Henderson, E. A. Collis, A. C. Mackinnon, K. J. Simpson, C. Haslett, R. Zent, M. Ginsberg, and T. Sethi
CD98hc (SLC3A2) Interaction with {beta}1 Integrins Is Required for Transformation
J. Biol. Chem., December 24, 2004; 279(52): 54731 - 54741.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Pompeia, D. R. Hodge, C. Plass, Y.-Z. Wu, V. E. Marquez, J. A. Kelley, and W. L. Farrar
Microarray Analysis of Epigenetic Silencing of Gene Expression in the KAS-6/1 Multiple Myeloma Cell Line
Cancer Res., May 15, 2004; 64(10): 3465 - 3473.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. A. Calderwood
Integrin activation
J. Cell Sci., March 1, 2004; 117(5): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liu, L. Charrier, A. Gewirtz, S. Sitaraman, and D. Merlin
CD98 and Intracellular Adhesion Molecule I Regulate the Activity of Amino Acid Transporter LAT-2 in Polarized Intestinal Epithelia
J. Biol. Chem., June 20, 2003; 278(26): 23672 - 23677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Shin, H. Wang, A. M. Yim, F. Le Naour, F. Brichory, J. H. Jang, R. Zhao, E. Puravs, J. Tra, C. W. Michael, et al.
Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function
J. Biol. Chem., February 21, 2003; 278(9): 7607 - 7616.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]